ViaLase Announces Positive Results of First In-Human Study of Femtosecond Laser Image-Guided High Precision Trabeculotomy (FLigHT)

Findings Presented at American Glaucoma Society Meeting Demonstrate Safety and Efficacyof ViaLase FLigHT Treatment ALISA VIEJO, CA — March 2, 2023 — ViaLase, Inc., a clinical stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm with the development of a truly non-invasive image-guided femtosecond laser treatment to enhance glaucoma […] The post ViaLase Announces Positive Results of First In-Human Study of Femtosecond Laser Image-Guided High Precision Trabeculotomy (FLigHT) appeared first on Vialase .